KYORIN and Eisai Enter Into License Agreement Concerning the Development and Marketing of Vibegron, a Treatment for Overactive Bladder,
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://www.kyorin-pharm.co.jp/en/news/KYORIN%20and%20Eisai%20Enter%20Into%20License%20Agreement%20Concerning%20the%20Development%20and%20Marketing%20of%20Vibegron%20in%20Four%20ASEAN%20Countries.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (2)
Alternatively, you can try searching for similar contracts:
